Related Experiment Video
Updated: May 2, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Transcatheter tricuspid valve treatment: a growing armamentarium of devices
Rodrigo Estevez-Loureiro1,2, Julio Echarte-Morales1,2, Nicole Karam3
1Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.
Abstract:
Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge repair is the most widely adopted approach, while replacement technologies are advancing rapidly and offer the potential for near-complete elimination of regurgitation. In parallel, annuloplasty, spacers, and caval devices are broadening the therapeutic spectrum across diverse anatomies. This review outlines the expanding device armamentarium and the key opportunities and challenges in this evolving field.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Heart Failure VI: Adjunct Therapies
Rheumatic Heart Disease III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

